The Grand Opening of the Innovation Center at the Zhejiang China and Or Yehuda Israel Industrial Cooperation Park was held on June 17th, simultaneously broadcasting from Hangzhou & Beijing in China, and Or-Yehuda in Israel.
The new innovation center is a result of on-going mutual cooperation and efforts of both the Chinese “Venus” and the Israeli “Cardiovalve”, that has recently signed a mutual cooperation agreement.
Cardiovalve's technology is a breakthrough in the cardiac valve disease treatment field based in Israel. Cardiovalve is a pioneer in the field of transcatheter valve replacement which help patients suffering from heart valve disease to access innovative solutions. Cardiovalve has applied for over 215 patents, of which 83 have been granted.
About Venus MedTech:
Venus MedTech is a leading, innovative Chinese structural heart disease treatment company. It is a medical device company that focus on development and commercialization of transcatheter heart valve products for structural heart diseases.
Recently, the two companies announced one of the largest deals signed in recent years between an Israeli and a Chinese company:
The acquisition is intended to expand Venus Medtech’s product layout of TMVR and TTVR technology, further enhance the company’s product pipeline in the field of cardiac valve disease treatment and accelerate its internationalization.
To further deepen the cooperation between the companies, DiNovA Medtech Group and Zhejiang government have worked together to create a digital medical device industry innovation platform with the goal of creating a national-level industrial innovation center, also known as "DiNovA Linping China-Israel Digital Medical Device Industry Innovation Center". This Center targets at pressing medical technology headaches, dedicates itself to the cutting-edge technologies in digital medicine, medical sensing and other fields, and accelerates the implementation and incubation of a number of high-end medical device projects, aiming to creating an internationally leading life and health industry and academic highland.
The event took place in 3 locations – Beijing, Hangzhou and Or-Yehuda.
Greeting speeches from both sides leader opened the event, followed by a signing ceremony and an Israeli companies’ roadshow.
From Beijing Embassy, the honorable Minister, Deputy Chief of Mission, Mr. Yuval Waks gave an inspiring speech, supported also by the Head of the Economic Mission to China at the Israeli Embassy in Beijing, Ms. Esti Ayalon Kovo.
以色列方面，以色列驻华公使、副大使Yuval Waks先生，以色列驻华使馆经济参赞Esti Ayalon Kovo女士分别发表了鼓舞人心的讲话。
From Hangzhou, Vice Governor, Mr. LU Shan
Mayor Mr. LIU Xin
Linping District Leaders ：Mr. CHEN Rugen, Mr. SHI Huamiao, Mr. GE Jianwei, Mr. ZHENG Ying,
Ministry of Industry and Information Technology, Mr. FANG Jiancheng
Head of DinovA Israel Global Innovation Center, Zhejiang government
Mr.Eric Zi and Mr. Micheal Zhao
Supporting Greeting speeches from Israel: The Minister of Science, Technology and Space Mrs. Orit Farkash-Hacohen, City Mayor of Or-Yehuda Mrs. Liat Shochat & Chairwoman of BioMed Israel Mrs. Ruthi Alon.
以色列创新和科技部部长Orit Farkash-Hacohen女士、耶胡达市市长Liat Shochat女士和以色列国际生命医学及生物医药展主席Ruthi Alon女士发来视频祝福。
The Israeli Chamber of Commerce in China (IsCham) salutes and supports IsCham’s member Cardiovalve and its CEO Mr. Amir Gross that their success represents the Israeli innovation entrepreneur spirit. IsCham will continue to support the business cooperation between the two nations, and welcome initiatives for new business cooperation from both sides .